{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:27:18Z","timestamp":1761658038671,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jmii.2016.11.006","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T20:30:44Z","timestamp":1498509044000},"page":"541-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Kazufumi","family":"Takamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Marumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motonari","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9131-0797","authenticated-orcid":false,"given":"Atsuko","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2016.11.006_bib1","doi-asserted-by":"crossref","first-page":"e1001053","DOI":"10.1371\/journal.pmed.1001053","article-title":"Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis","volume":"8","author":"Van Kerkhove","year":"2011","journal-title":"PLoS Med"},{"year":"2016","series-title":"Influenza antiviral medications: summary for clinicians","key":"10.1016\/j.jmii.2016.11.006_bib2"},{"key":"10.1016\/j.jmii.2016.11.006_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3851\/IMP2442","article-title":"A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults","volume":"18","author":"Ison","year":"2016","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.jmii.2016.11.006_bib4","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/AAC.00360-11","article-title":"Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.11.006_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/crj.12129","article-title":"Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan","volume":"9","author":"Yoshino","year":"2015","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jmii.2016.11.006_bib6","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/AAC.45.12.3403-3408.2001","article-title":"Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants","volume":"45","author":"Gubareva","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.11.006_bib7","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/AAC.01718-10","article-title":"Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.11.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13580","article-title":"Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation","volume":"13","author":"Burch","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jmii.2016.11.006_bib9","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1128\/AAC.00474-10","article-title":"Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection","volume":"54","author":"Kohno","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2016.11.006_bib10","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"7","author":"Rodrigo","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217300750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:22:15Z","timestamp":1761657735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118217300750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1684118217300750"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2016.11.006","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}